Market revenue in 2023 | USD 17.3 million |
Market revenue in 2030 | USD 37.0 million |
Growth rate | 11.5% (CAGR from 2023 to 2030) |
Largest segment | Oligonucleotide synthesis |
Fastest growing segment | Gene Synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotide Synthesis, Gene Synthesis |
Key market players worldwide | Thermo Fisher Scientific Inc, Twist Bioscience Corp, Codexis Inc, LGC Group, Eurofins Scientific SE, Genscript Biotech Corp Class H, Bioneer, IBA Lifesciences, Danaher Corp, Quintarabio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna synthesis market will help companies and investors design strategic landscapes.
Oligonucleotide synthesis was the largest segment with a revenue share of 55.49% in 2023. Horizon Databook has segmented the Argentina dna synthesis market based on oligonucleotide synthesis, gene synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
The country experiences a growing burden of chronic diseases, such as cancer, diabetes, and cardiovascular conditions. This is expected to necessitate the demand for advanced diagnostic and therapeutic interventions, potentially utilizing DNA, propelling market growth.
In addition, DNA synthesis enables the creation of nucleic acid sequences, such as ASOs and aptamers, which can be utilized to modulate gene expression, disrupt specific protein functions, or target key molecules associated with diabetes.
Furthermore, Argentina has a high prevalence of diabetes, which creates an opportunity for the DNA synthesis market. According to the International Diabetes Federation, in 2021, Argentina recorded 1.8 million cases of diabetes and a 6.1% prevalence in adults.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina dna synthesis market, including forecasts for subscribers. This country databook contains high-level insights into Argentina dna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account